>>Signaling Pathways>> Stem Cell>> Casein Kinase>>AMG-548 dihydrochloride

AMG-548 dihydrochloride

Catalog No.GC38518

경구 활성 및 선택적 p38α 억제제(Ki=0.5nM)인 AMG-548 디히드로클로라이드는 p38β(Ki=36nM)에 대해 약간 선택적이고 p38γ 및 p38δ에 대해 >1000배 선택성을 나타낸다.

Products are for research use only. Not for human use. We do not sell to patients.

AMG-548 dihydrochloride Chemical Structure

Size 가격 재고 수량
1mg
US$81.00
재고 있음
5mg
US$243.00
재고 있음
10mg
US$405.00
재고 있음
25mg
US$810.00
재고 있음
50mg
US$1,305.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

AMG-548 dihydrochloride, a potent, orally active and selective p38α inhibitor (Ki=0.5 nM), shows slightly selective over p38β (Ki=36 nM) and >1000 fold selective against p38γ and p38δ. AMG-548 dihydrochloride is also extremely potent in the inhibition of whole blood LPS stimulated TNFα (IC50=3 nM)[1]. AMG-548 dihydrochloride inhibits Wnt signaling by directly inhibiting Casein kinase 1 isoforms δ and ε[2].

AMG-548 dihydrochloride has rat F of 62% and dog F of 47%. The t1/2 is 4.6 hours in rats and 7.3 hours in dogs[1].

[1]. Lee MR, et al. MAP kinase p38 inhibitors: clinical results and an intimate look at their interactions with p38alphaprotein. Curr Med Chem. 2005;12(25):2979-94. [2]. Verkaar F, et al. Inhibition of Wnt/β-catenin signaling by p38 MAP kinase inhibitors is explained by cross-reactivity with casein kinase Iδ/?. Chem Biol. 2011 Apr 22;18(4):485-94.

리뷰

Review for AMG-548 dihydrochloride

Average Rating: 5 ★★★★★ (Based on Reviews and 7 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for AMG-548 dihydrochloride

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.